List of works - Lucija Peterlin-Masic

Analogues of the Lignan Pinoresinol as Novel Lead Compounds for P-glycoprotein (P-gp) Inhibitors

scientific article published on 21 November 2018

Applicability of the OECD 455 in-vitro assay for determination of hERa agonistic activity of isoflavonoids

scientific article published on 20 November 2019

Bazedoxifene-scaffold-based mimetics of solomonsterols A and B as novel pregnane X receptor antagonists.

scientific article published on 28 May 2014

Bioactivation potential of thiophene-containing drugs.

scientific article published on 21 July 2014

Bisphenol A and its analogs: Do their metabolites have endocrine activity?

scientific article

Data on biosynthesis of BPAF glucuronide, enzyme kinetics of BPAF glucuronidation, and molecular modeling

scientific article published on 17 December 2018

Design, Synthesis, and Evaluation of Novel Tyrosine-Based DNA Gyrase B Inhibitors.

scientific article published on 16 June 2017

Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10

scientific article published on 30 December 2014

Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors

scientific article

Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase

scientific article

Efflux pump inhibitors of clinically relevant multidrug resistant bacteria

scientific article published on 19 April 2019

Evaluation of endocrine activities of ellagic acid and urolithins using reporter gene assays

scientific article published on 26 December 2018

Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids

scientific article

Inhibition of biofilm formation by conformationally constrained indole-based analogues of the marine alkaloid oroidin

scientific article published on 08 April 2014

MurD enzymes from different bacteria: Evaluation of inhibitors

scientific article published on 15 June 2012

Mutagenicity and DNA damage of bisphenol A and its structural analogues in HepG2 cells.

scientific article published on June 2013

N-Phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATP Competitive DNA Gyrase B Inhibitors: Design, Synthesis, and Evaluation

scientific article

New N-phenyl-4,5-dibromopyrrolamides as DNA gyrase B inhibitors

scientific article published on 20 May 2019

New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity

scientific article published on 10 May 2018

New brominated flame retardants and their metabolites as activators of the pregnane X receptor.

scientific article published on 6 August 2016

Novel agents aiming at specific molecular targets increase chemosensitivity and overcome chemoresistance in hematopoietic malignancies

scientific article

Novel thrombin inhibitors incorporating non-basic partially saturated heterobicyclic P1-arginine mimetics

scientific article

Novel thrombin inhibitors incorporating weakly basic heterobicyclic P1-arginine mimetics: optimization via modification of P1 and P3 moieties.

scientific article

Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes

scientific article published on 10 July 2018

Rational design of balanced dual-targeting antibiotics with limited resistance

scientific article published on 05 October 2020

Recent advances in the discovery of tissue factor/factor VIIa inhibitors and dual inhibitors of factor VIIa/factor Xa.

scientific article

Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation.

scientific article

Selective 3-amino-2-pyridinone acetamide thrombin inhibitors incorporating weakly basic partially saturated heterobicyclic P1-arginine mimetics

scientific article published in October 2003

List of works by Lucija Peterlin-Masic

Analogues of the Lignan Pinoresinol as Novel Lead Compounds for P-glycoprotein (P-gp) Inhibitors

Applicability of the OECD 455 in-vitro assay for determination of hERa agonistic activity of isoflavonoids

Bazedoxifene-scaffold-based mimetics of solomonsterols A and B as novel pregnane X receptor antagonists.

Bioactivation potential of thiophene-containing drugs.

Bisphenol A and its analogs: Do their metabolites have endocrine activity?

Data on biosynthesis of BPAF glucuronide, enzyme kinetics of BPAF glucuronidation, and molecular modeling

Design, Synthesis, and Evaluation of Novel Tyrosine-Based DNA Gyrase B Inhibitors.

Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10

Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors

Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase

Efflux pump inhibitors of clinically relevant multidrug resistant bacteria

Evaluation of endocrine activities of ellagic acid and urolithins using reporter gene assays

Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids

Inhibition of biofilm formation by conformationally constrained indole-based analogues of the marine alkaloid oroidin

MurD enzymes from different bacteria: Evaluation of inhibitors

Mutagenicity and DNA damage of bisphenol A and its structural analogues in HepG2 cells.

N-Phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATP Competitive DNA Gyrase B Inhibitors: Design, Synthesis, and Evaluation

New N-phenyl-4,5-dibromopyrrolamides as DNA gyrase B inhibitors

New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity

New brominated flame retardants and their metabolites as activators of the pregnane X receptor.

Novel agents aiming at specific molecular targets increase chemosensitivity and overcome chemoresistance in hematopoietic malignancies

Novel thrombin inhibitors incorporating non-basic partially saturated heterobicyclic P1-arginine mimetics

Novel thrombin inhibitors incorporating weakly basic heterobicyclic P1-arginine mimetics: optimization via modification of P1 and P3 moieties.

Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes

Rational design of balanced dual-targeting antibiotics with limited resistance

Recent advances in the discovery of tissue factor/factor VIIa inhibitors and dual inhibitors of factor VIIa/factor Xa.

Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation.

Selective 3-amino-2-pyridinone acetamide thrombin inhibitors incorporating weakly basic partially saturated heterobicyclic P1-arginine mimetics